Author details

Full Name

Johannes H Schulte

Affiliation

ORCID

Career Start Year

2003

Papers

190

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36854071	Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.	J Clin Oncol	2023
35899825	Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma.	Cancer Rep (Hoboken)	2023
36134454	Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study.	Haematologica	2023
37942315	Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients.		2023
37868040	Mutational topography reflects clinical neuroblastoma heterogeneity.	Cell Genom	2023
37402719	Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.	Nat Commun	2023
37142849	Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells.	Nat Genet	2023
36882421	SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.	Nat Commun	2023
36875143	Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous disease.		2023
37386249	Single-cell multi-omics of mitochondrial DNA disorders reveals dynamics of purifying selection across human immune cells.	Nat Genet	2023
36870963	Molecular characterization of the circadian clock in paediatric leukaemia patients: a prospective study protocol.		2023
36807339	Genomic ALK alterations in primary and relapsed neuroblastoma.	Br J Cancer	2023
37246217	IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.		2023
37302792	Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome.	J Allergy Clin Immunol Pract	2023
36794500	Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation.		2023
34387727	Correction to: Long-term small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia after stem cell transplantation.	Journal of Cancer Research and Clinical Oncology	2022
35879366	Therapeutic targeting of ATR in alveolar rhabdomyosarcoma.	Nature Communications	2022
35689207	Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells.	Mol Cancer	2022
35565208	Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics.	Cancers	2022
36070299	Generation of full-length circular RNA libraries for Oxford Nanopore long-read sequencing.	PLoS ONE	2022
35613412	Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring an <i>NTRK</i> Oncogenic Fusion.	JCO Precis Oncol	2022
35720367	Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders - Outcome After Hematopoietic Stem Cell Transplantation.	Frontiers in Immunology	2022
36700232	Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model.		2022
33661164	Hemostatic Management in an Infant With Neuroblastoma and Severe Hemophilia B With Extended Half-life Recombinant Factor IX Fusion Protein.	Journal of Pediatric Hematology/Oncology	2022
35247920	Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.	Clinical Cancer Research	2022
34815394	Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.	Nat Commun	2021
33801448	CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus.	Cancers	2021
34285106	GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma.	Journal for ImmunoTherapy of Cancer	2021
33572828	Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma.	Children	2021
33947691	ALK Inhibitors in Neuroblastoma: A Sprint from Bench to Bedside.	Clinical Cancer Research	2021
34267756	A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization.	Frontiers in Immunology	2021
34202325	Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging.	Cancers	2021
34097656	Hematopoietic Stem Cell Transplantation Cures Therapy-refractory Aspergillosis in Chronic Granulomatous Disease.	Pediatric Infectious Disease Journal	2021
34026620	The MicroRNA Landscape of MYCN-Amplified Neuroblastoma.	Frontiers in Oncology	2021
34244664	Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.	Bone Marrow Transplant	2021
33919815	Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria.	Cancers (Basel)	2021
33098344	Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.	Pediatric Transplantation	2021
33284994	Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.	International Journal of Cancer	2021
33118209	Outcome of chronic granulomatous disease - Conventional treatment vs stem cell transplantation.	Pediatr Allergy Immunol	2021
34735429	Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance.	PLoS Computational Biology	2021
34442335	Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing.	J Pers Med	2021
34780709	Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.	Lancet Oncol	2021
34379779	Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus Infections.	Journal of the Pediatric Infectious Diseases Society	2021
34771652	Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis.	Cancers	2021
30988380	Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications.	Bone Marrow Transplantation	2020
31850671	Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA-DPB1 typing.	Pediatric Blood and Cancer	2020
31844324	Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.	Nat Genet	2020
32312912	Oncogenic <i>ALK</i> <sup><i>F1174L</i></sup> drives tumorigenesis in cutaneous squamous cell carcinoma.	Life Sci Alliance	2020
32296437	Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4 CAR T Cell Efficacy.	Frontiers in Immunology	2020
31937834	The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.	Sci Rep	2020